1. Home
  2. TRDA vs TWIN Comparison

TRDA vs TWIN Comparison

Compare TRDA & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$6.21

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$26.30

Market Cap

320.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
TWIN
Founded
2016
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
320.9M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
TRDA
TWIN
Price
$6.21
$26.30
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $21.00
N/A
AVG Volume (30 Days)
★ 290.0K
67.1K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
★ 0.98%
EPS Growth
N/A
★ 1428.57
EPS
N/A
★ 1.86
Revenue
$25,421,000.00
★ $381,270,000.00
Revenue This Year
$39.97
$10.79
Revenue Next Year
$50.80
$8.43
P/E Ratio
★ N/A
$14.05
Revenue Growth
N/A
★ 11.90
52 Week Low
$5.56
$13.42
52 Week High
$16.45
$26.67

Technical Indicators

Market Signals
Indicator
TRDA
TWIN
Relative Strength Index (RSI) 36.70 66.80
Support Level $5.71 $22.13
Resistance Level $7.89 N/A
Average True Range (ATR) 0.39 0.88
MACD -0.09 0.17
Stochastic Oscillator 13.85 85.53

Price Performance

Historical Comparison
TRDA
TWIN

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: